Washington, September 23: As against the findings of all previous studies on vitamin E, a new research has now suggested that the levels of the micronutrient that have been commonly used in clinical trials to reduce oxidative stress so far have been far lower than what they actually should be.

Washington: Scientists had discovered many ways to stimulate the body’s own anti-aging protections maybe with a pill, which could battle various diseases at a time.

The study, which is published in the journal ‘Cell’, helps explicating why animals fed very light foods live a longer life, but it also provides new ways to aspire to reproduce the outcomes of these diets using a pill in place of hunger.

Washington, September 22 : A new study has shown that language impairment may affect a child’s ability to understand and retell a script-based story.

The study, involving a researcher from the University of Alberta, is the first to look into the relationship between language skills and children’s ability to understand things.

When a person experiences an event frequently, for instance going to a restaurant, he remembers the kinds of activities that are part of such event. This is called a ‘script’.

Washington, September 22 : A Queen’s researcher has suggested that women’s desire to marry and have children is governed by the genes they inherit from their maternal ancestors, rather than the new found newfound economic independence.

Lonnie Aarssen, a Biology professor who specializes in reproductive ecology, believes that though many women have become more inclined to making their career instead of starting their families, this trend will change in future.

Washington, Sept 22 : Researchers have patented a synthetic version of the drug heparin, called Recomparin, that is less complex chemically and easier to produce than previous forms.

Heparin has loads of advantages such as it helps in preventing clots from forming and restricting the flow of blood during and after procedures such as kidney dialysis, heart-bypass surgery, stent implantation and knee and hip replacement. The annual worldwide sales of the drug are estimated at 3 billion dollars.